Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tasegian

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Molecular Diagnostics|June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's diseaseLucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
The Biochemical Journal|September 13, 2021
Impact of Type II LRRK2 inhibitors on signaling and mitophagyAnna Tasegian, Francois Singh, Ian G Ganley, et al.
The Journal of Biological Chemistry|February 20, 2014
Accumulation of free oligosaccharides and tissue damage in cytosolic α-mannosidase (Man2c1)-deficient miceSilvia Paciotti, Emanuele Persichetti, Katharina Klein, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Lysosomal alpha-mannosidase and alpha-mannosidosisSilvia Paciotti, Michela Codini, Anna Tasegian, et al.
Nature Immunology|October 8, 2024
LRRK2 is not required for lysozyme expression in Paneth cellsAnna Tasegian, Dina Dikovskaya, Molly M Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patientsLucilla Parnetti, Silvia Paciotti, Paolo Eusebi, et al.
Mediators of Inflammation|February 24, 2016
Hypovitaminosis D3, Leukopenia, and Human Serotonin Transporter Polymorphism in Anorexia Nervosa and Bulimia NervosaAnna Tasegian, Francesco Curcio, Laura Dalla Ragione, et al.
Molecular Neurodegeneration|April 17, 2015
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodiesDavide Chiasserini, Silvia Paciotti, Paolo Eusebi, et al.
Lipids in Health and Disease|January 13, 2016
Why high cholesterol levels help hematological malignancies: role of nuclear lipid microdomainsMichela Codini, Samuela Cataldi, Andrea Lazzarini, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 21, 2019
5-HT2AR and BDNF gene variants in eating disorders susceptibilityM Rachele Ceccarini, Anna Tasegian, Marica Franzago, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's diseaseLucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
The Biochemical Journal|September 13, 2021
Impact of Type II LRRK2 inhibitors on signaling and mitophagyAnna Tasegian, Francois Singh, Ian G Ganley, et al.
The Journal of Biological Chemistry|February 20, 2014
Accumulation of free oligosaccharides and tissue damage in cytosolic α-mannosidase (Man2c1)-deficient miceSilvia Paciotti, Emanuele Persichetti, Katharina Klein, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Lysosomal alpha-mannosidase and alpha-mannosidosisSilvia Paciotti, Michela Codini, Anna Tasegian, et al.
Nature Immunology|October 8, 2024
LRRK2 is not required for lysozyme expression in Paneth cellsAnna Tasegian, Dina Dikovskaya, Molly M Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patientsLucilla Parnetti, Silvia Paciotti, Paolo Eusebi, et al.
Mediators of Inflammation|February 24, 2016
Hypovitaminosis D3, Leukopenia, and Human Serotonin Transporter Polymorphism in Anorexia Nervosa and Bulimia NervosaAnna Tasegian, Francesco Curcio, Laura Dalla Ragione, et al.
Molecular Neurodegeneration|April 17, 2015
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodiesDavide Chiasserini, Silvia Paciotti, Paolo Eusebi, et al.
Lipids in Health and Disease|January 13, 2016
Why high cholesterol levels help hematological malignancies: role of nuclear lipid microdomainsMichela Codini, Samuela Cataldi, Andrea Lazzarini, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 21, 2019
5-HT2AR and BDNF gene variants in eating disorders susceptibilityM Rachele Ceccarini, Anna Tasegian, Marica Franzago, et al.
Pageof 2